Embla Medical Statistics
Total Valuation
Embla Medical has a market cap or net worth of 1.74 billion. The enterprise value is 2.19 billion.
| Market Cap | 1.74B |
| Enterprise Value | 2.19B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.51% |
| Shares Change (QoQ) | -3.47% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 161.07M |
Valuation Ratios
The trailing PE ratio is 25.44.
| PE Ratio | 25.44 |
| Forward PE | n/a |
| PS Ratio | 2.03 |
| PB Ratio | 2.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 19.51 |
| P/OCF Ratio | 14.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.01, with an EV/FCF ratio of 24.65.
| EV / Earnings | 32.14 |
| EV / Sales | 2.34 |
| EV / EBITDA | 12.01 |
| EV / EBIT | 17.07 |
| EV / FCF | 24.65 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.64.
| Current Ratio | 1.90 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 3.06 |
| Debt / FCF | 5.61 |
| Interest Coverage | 4.89 |
Financial Efficiency
Return on equity (ROE) is 9.28% and return on invested capital (ROIC) is 5.80%.
| Return on Equity (ROE) | 9.28% |
| Return on Assets (ROA) | 4.86% |
| Return on Invested Capital (ROIC) | 5.80% |
| Return on Capital Employed (ROCE) | 8.55% |
| Revenue Per Employee | 210,512 |
| Profits Per Employee | 16,813 |
| Employee Count | 4,061 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.78% in the last 52 weeks. The beta is 0.57, so Embla Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -7.78% |
| 50-Day Moving Average | 4.55 |
| 200-Day Moving Average | 5.69 |
| Relative Strength Index (RSI) | 39.62 |
| Average Volume (20 Days) | 10,321 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Embla Medical had revenue of 854.89 million and earned 68.28 million in profits. Earnings per share was 0.16.
| Revenue | 854.89M |
| Gross Profit | 534.70M |
| Operating Income | 113.75M |
| Pretax Income | 90.56M |
| Net Income | 68.28M |
| EBITDA | 137.92M |
| EBIT | 113.75M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 86.16 million in cash and 499.79 million in debt, giving a net cash position of -413.63 million.
| Cash & Cash Equivalents | 86.16M |
| Total Debt | 499.79M |
| Net Cash | -413.63M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 780.70M |
| Book Value Per Share | 1.82 |
| Working Capital | 187.67M |
Cash Flow
In the last 12 months, operating cash flow was 116.07 million and capital expenditures -27.03 million, giving a free cash flow of 89.03 million.
| Operating Cash Flow | 116.07M |
| Capital Expenditures | -27.03M |
| Free Cash Flow | 89.03M |
| FCF Per Share | n/a |
Margins
Gross margin is 62.55%, with operating and profit margins of 13.31% and 7.99%.
| Gross Margin | 62.55% |
| Operating Margin | 13.31% |
| Pretax Margin | 10.59% |
| Profit Margin | 7.99% |
| EBITDA Margin | 16.13% |
| EBIT Margin | 13.31% |
| FCF Margin | 10.41% |
Dividends & Yields
Embla Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.51% |
| Shareholder Yield | -1.51% |
| Earnings Yield | 3.93% |
| FCF Yield | 5.13% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Embla Medical has an Altman Z-Score of 3.17.
| Altman Z-Score | 3.17 |
| Piotroski F-Score | n/a |